FDA approves first pill to treat moderate-to-severe Crohn's disease
Patients with Crohn's disease have a new treatment option, following U.S. Food and Drug Administration approval of a pill called Rinvoq (upadacitinib).
May 19, 2023
0
2
Patients with Crohn's disease have a new treatment option, following U.S. Food and Drug Administration approval of a pill called Rinvoq (upadacitinib).
May 19, 2023
0
2
Feeling safe where you live may be key to weight loss, the European Congress on Obesity (ECO) in Dublin, Ireland (May 17-20) will hear.
May 18, 2023
0
18
A new sub-study of the STEP TEENS trial, presented at this year's European Congress on Obesity (ECO) 2023 in Dublin May 17-20, shows that adolescents using semaglutide experienced significant reductions in levels of liver ...
May 17, 2023
0
2
Past obesity is associated with worse current mental health and this may increase risk of dying early, regardless of current weight status, suggests research being presented at the European Congress on Obesity (ECO) in Dublin, ...
May 17, 2023
0
27
Sarcopenia is the progressive and accelerated loss of muscle mass and strength as we age.
May 17, 2023
0
34
A new treatment for overweight and obesity combining the world's first and only procedure-free swallowable gastric balloon—that is placed without surgery, endoscopy or anesthesia and passes out of the body naturally after ...
May 16, 2023
0
12
Ear acupuncture using metal beads can help reduce weight, body mass index (BMI), and body fat in combination with a restricted diet, according to new research being presented at this year's European Congress on Obesity (ECO) ...
May 16, 2023
0
4
A DGIST research team led by Professor Kyungmoo Yea of the Department of New Biology developed an antibody that effectively alleviates chemotherapy-induced cancer cachexia. The team's newly developed antibody not only improves ...
May 12, 2023
0
35
Danish drugmaker Novo Nordisk said Thursday it will limit distribution of its low-dose versions of the wildly popular weight-loss drug Wegovy, to ensure that people already taking the drug will have enough supply.
May 5, 2023
0
2
Diabetes risk perception and awareness are not associated with greater engagement in risk-reducing behaviors among U.S. youth aged 12 to 17 years with overweight or obesity, according to a study published online May 3 in ...
May 5, 2023
0
6